Table 3. Chain-breaking activity, radical scavenging (DPPH assay), inhibition of human serum lipid oxidation (TBARS), nitric oxide (NO) scavenging assay, and inhibition of angiotensin-converting enzyme (ACE) of infusions and fermented beverages with kombucha consortium.
| Chain-breaking activity | IC50/(µg/µL) | |||||
|---|---|---|---|---|---|---|
| –1/(min/mg) | DPPH | TBARS | NO | ACE inhibition | ||
| Litsea glaucescens | ||||||
| Infusion | (5.1±0.4)a | (4.6±0.1)a | (1.9±0.1)a | (22.4±6.3)a | (0.70±0.02)c | |
| Fermented beverage | (5.2±0.1)a | (2.70±0.01)b | (1.1±0.1)a | (11.4±1.3)b | (1.08±0.01)b | |
| Eucalyptus camaldulensis | ||||||
| Infusion | (3.7±0.2)b | (3.40±0.05)c | (0.36±0.01)b | (6.7±0.9)c | (1.40±0.05)b | |
| Fermented beverage | (3.0±0.1)b | (2.7±0.1)b | (1.0±0.3)a | (5.8±0.8)c | (2.61±0.01)a | |
| Catechin | (1.0±0.1)c | (3.8±0.1)c | (1.0±0.2)a | (2.5±0.3)d | –––– | |
| Captopril | N.D. | N.D. | N.D. | N.D. | (2.8±0.2)a | |
Values are means of duplicate determinations±standard error. Different letters in each column indicate statistical difference (p≤0.05) by Tukey’s test. N.D.=not determined